Who is affected by this change?

This affects Independence Blue Cross Oncology, Hematology providers on Commercial plans.

When does this change take effect?

This change is effective Mar 5, 2025.

Back to dashboard

CommercialCoverageMedium impact

08.02.16, Talquetamab-tgvs (Talvey™)

Independence Blue Cross·Oncology, Hematology·Pharmacy

Effective date

Mar 5, 2025

We identified it

Jun 19, 2026

Days to comply

—

Summary

This is a reissue of an existing policy for Talquetamab-tgvs (Talvey™), a specialty pharmacy drug. The policy has been updated for commercial insurance plans with an effective date of March 5, 2025.

Action Required

Action needed

By March 5, 2025: Billing team should review the updated Talquetamab-tgvs (Talvey™) policy at the provided URL to understand any changes to coverage criteria, prior authorization requirements, or billing procedures for this specialty drug. Update billing protocols accordingly for commercial plans.

Related policy hubs

Independence Blue Cross policies Oncology Hematology